Justice ministry confirms legal aid requests in Greece-Novartis scandal
Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access
Keystone
Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials.
This content was published on
2 minutes
SDA-ATS/RTS/sb
The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed to Swiss public television, RTS, and the Swiss News Agency on Saturday.
The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based NovartisExternal link over nearly a decade to boost subscriptions of their products at public hospitals. The ten prominent politicians linked to the bribery scandal include two former Greek prime ministers and eight former ministers. They are alleged to have been involved in approving Novartis contracts and overcharging in return for kickbacks. All deny the allegations.
Greece’s Justice Minister Stavros Kontonis last year said Novartis had likely bribed “thousands” of doctors and civil servants to promote its products. He also accused Novartis of continuing to sell “overpriced” drugs even after the country was plunged into economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine.
Novartis overcharges alone are estimated to have cost the Greek state some €3 billion euros ($3.7 billion). Overall, similar practises across the health sector cost Greece some €23 billion between 2000 and 2015, investigators have said.
The Greek branch of Novartis has issued a statement saying it was “aware of the media reports about our business practices” in Greece and that it was cooperating with the authorities, the Swiss News Agency said.
More
More
Greece investigates Novartis for alleged bribery
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Austrian right-wing extremist arrested by Swiss police
This content was published on
The Austrian right-wing extremist Martin Sellner entered Switzerland on Saturday despite being banned from entering the country.
All Swiss listed companies have a climate strategy
This content was published on
All major listed Swiss companies have a climate strategy. This puts Switzerland ahead of neighbouring Germany and Austria, says a study by Kirchhoff Consult and BDO.
Local birds are stars of this year’s Bern light show
This content was published on
The Rendez-vous Bundesplatz light show enters a new round on Saturday. This year, birds will be chirping, squawking and fluttering all over the façade of the federal parliament.
EU urges countries to keep demining in Ukraine permanently on the agenda
This content was published on
The Lausanne Ministerial Conference on Humanitarian Demining in Ukraine led to pledges from more than 40 countries to help the war-torn country.
This content was published on
Researchers at the University of Zurich have used artificial intelligence to detect antibiotic-resistant germs for the first time.
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
This content was published on
Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
This content was published on
The employees are believed to have offered illegal rebates and kickbacks to doctors amounting to 2.6 billion won (CHF 2.3 million) between 2011 and 2016. Altogether, 34 people – including 15 doctors and five heads of medical journals – have been included in the investigation, which began in February when authorities raided the Novartis Korea…
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
This content was published on
Swiss pharmaceutical giant Novartis has dismissed claims from an internal whistleblower that it bribed Turkish officials.
Pharma turns to big data to gauge care and pricing
This content was published on
Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.